SCOTT ISPIRESCU: Open Payments
NPI 1023148525 · MISSION VIEJO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,734 in 62 payments from 16 companies in 2025. Trend: 2023 $2,043 · 2024 $1,183 · 2025 $1,734
Food & beverage: $1,719Travel & lodging: $15
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 5 | $254 |
| Axsome Therapeutics, Inc. | 7 | $199 |
| E.R. Squibb & Sons, L.L.C. | 4 | $193 |
| ABBVIE INC. | 5 | $186 |
| Supernus Pharmaceuticals, Inc. | 7 | $131 |
| Collegium Pharmaceutical, Inc. | 6 | $125 |
| Otsuka America Pharmaceutical, Inc. | 5 | $112 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $102 |
| Teva Pharmaceuticals USA, Inc. | 4 | $99 |
| Vanda Pharmaceuticals Inc. | 3 | $81 |
Products named: INGREZZA, Auvelity, COBENFY, VRAYLAR, REXULTI, Jornay PM, CAPLYTA, UZEDY.
Industry payments across CA — which companies pay providers there.
